← Back to guidelines
Oncology41 papers

Squamous cell carcinoma of penis

Last edited: 4/10/2026

Overview

Squamous cell carcinoma (SCC) of the penis is an uncommon malignancy. Treatment should be managed at an expert center 1.

Diagnosis

No information on diagnosis was provided in the abstracts.

Management

  • Exclusive brachytherapy is indicated for early-stage penile glans cancer, yielding excellent disease control and organ preservation 1.
  • External beam radiation therapy (EBRT) may be considered in the palliative setting for primary tumor irradiation 1.
  • EBRT (with or without chemotherapy) can be discussed for lymph node irradiation as a neoadjuvant approach for massive inguinal lymph node invasion or as an adjuvant approach for high-risk relapse 1.
  • These latter indications for EBRT require individual discussion due to poor evidence levels 1.
  • Special Populations

    No information on special populations was provided in the abstracts.

    Key Recommendations

  • Exclusive brachytherapy is recommended for early-stage penile glans cancer for disease control and organ preservation 1. (Evidence: Moderate)
  • External beam radiation therapy may be considered for palliative treatment of the primary penile tumor 1. (Evidence: Weak)
  • External beam radiation therapy with or without chemotherapy can be considered for inguinal lymph node irradiation in specific neoadjuvant or adjuvant settings, but requires individual assessment due to limited evidence 1. (Evidence: Weak)
  • References

    1 Escande A, Peiffert D, Dejean C, Hannoun-Lévi JM, Cordoba A, Pommier P et al.. Radiotherapy for penile cancers. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2022. link

    Original source

    1. [1]
      Radiotherapy for penile cancers.Escande A, Peiffert D, Dejean C, Hannoun-Lévi JM, Cordoba A, Pommier P et al. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG